Arthritis: all 3,553 studies

Page 11 of 36. Open to participants first (311), then studies with results posted, then the rest; newest registration first within each.

• Safety Study of HZT-501 in Patients Who Require Long-Term Daily Non-steroidal Anti-inflammatory Drug TreatmentCompletedNCT00984815Phase 3Results posted
• TORPEDO Study: A Study on Rapid Effect of Tocilizumab in Patients With Rheumatoid Arthritis With an Inadequate Response to Disease-Modifying Antirheumatic Drugs (DMARDs) or Anti-TNFCompletedNCT00977106Phase 3Results posted
• A Study To Evaluate The Mechanism Of Action Of CP-690,550 In Patients With Rheumatoid ArthritisCompletedNCT00976599Phase 2Results posted
• Subcutaneous Golimumab (GLM) Plus DMARDs for Rheumatoid Arthritis, Followed by Intravenous/Subcutaneous GLM Strategy (P06129 AM2)CompletedNCT00975130Phase 3Results posted
• An Effectiveness and Safety Study of Intravenous Golimumab in Patients With Active Rheumatoid Arthritis Despite Treatment With Methotrexate TherapyCompletedNCT00973479Phase 3Results posted
• Intra-articular Glucocorticoid Treatment of the ElbowCompletedNCT00972530Not applicableResults posted
• A Study in Patients With Rheumatoid ArthritisCompletedNCT00966875Phase 2Results posted
• A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Combination Therapy of T-614 and Methotrexate in Rheumatoid Arthritis Patients With an Inadequate Response to MethotrexateCompletedNCT00965757Phase 3Results posted
• Study Evaluating Etanercept in 3 Subtypes of Childhood ArthritisCompletedNCT00962741Phase 3Results posted
• Study of CP-690,550 Versus Placebo In Rheumatoid Arthritis Patients On Background Methotrexate With Inadequate Response To Tumor Necrosis Factor (TNF) InhibitorsCompletedNCT00960440Phase 3Results posted
• A Study of Tocilizumab + DMARDs in Patients With Moderate to Severe Active Rheumatoid ArthritisCompletedNCT00951275Phase 3Results posted
• Brodalumab (AMG 827) in Rheumatoid Arthritis (RA) Participants With Inadequate Response to MethotrexateCompletedNCT00950989Phase 2Results posted
• Sleep and Immunity in Rheumatoid Arthritis : Remicade SubstudyCompletedNCT00948610Not applicableResults posted
• Study Evaluating Safety and Adherence to Treatment With Etanercept in Adults With Psoriatic ArthritisCompletedNCT00938015Results posted
• A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to MethotrexateCompletedNCT00934648Phase 4Results posted
• Abatacept Versus Adalimumab Head-to-HeadCompletedNCT00929864Phase 3Results posted
• Retrospective Evaluation of the Radiographic Efficacy of Conventional and Biologic TreatmentCompletedNCT00929357Results posted
• Efficacy, Safety and Tolerability of AIN457 in Patients With Rheumatoid Arthritis (RA) Taking Methotrexate (MTX)CompletedNCT00928512Phase 2Results posted
• First-in-man Trial of NNC0142-0002 in Patients With Rheumatoid ArthritisCompletedNCT00927927Phase 1Results posted
• Long Term Study of Canakinumab (ACZ885) in Patients With GoutCompletedNCT00927810Phase 2Results posted
• Study Evaluating Etanercept Plus Methotrexate in Early Rheumatoid ArthritisCompletedNCT00913458Phase 4Results posted
• Study of LX3305 in Subjects With Active Rheumatoid Arthritis on Stable MethotrexateCompletedNCT00903383Phase 2Results posted
• INCB028050 Compared to Background Therapy in Patients With Active Rheumatoid Arthritis (RA) With Inadequate Response to Disease Modifying Anti-Rheumatic DrugsCompletedNCT00902486Phase 2Results posted
• An Efficacy and Safety Study of Infliximab in Participants With Rheumatoid ArthritisCompletedNCT00896168Phase 4Results posted
• An Open-label Extension Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis and Active Systemic Manifestations Manifestations and Response Characterization Study in Canakinumab Treatment-naïve Patients With Active SJIA With and Without Fever.CompletedNCT00891046Phase 3Results posted
• A Study Of Tocilizumab in Patients With Moderate to Severe Active Rheumatoid Arthritis Who Have an Inadequate Response to or Are Unable to Tolerate Biologic and Non-Biologic Disease-modifying Antirheumatic Drugs (DMARDs)CompletedNCT00891020Phase 3Results posted
• Flare Prevention Study of Canakinumab in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA)CompletedNCT00889863Phase 3Results posted
• A Study Comparing Infusion Rates of Tocilizumab in Patients With Moderate to Severe Rheumatoid ArthritisCompletedNCT00887341Phase 2Results posted
• Single-dose Study to Assess Efficacy of Canakinumab (ACZ885) in Patients With Active Juvenile Idiopathic Arthritis (SJIA)TerminatedNCT00886769Phase 3Results posted
• Study To Evaluate The Safety And Efficacy Of ILV-094 In Subjects With Rheumatoid ArthritisCompletedNCT00883896Phase 2Results posted
• An Extension to Study MA21573, Evaluating Tocilizumab in Patients With Active Rheumatoid Arthritis and an Inadequate Response to Current Non-Biological DMARDs and/or Anti-tumor Necrosis Factor (TNF) TherapyCompletedNCT00883753Phase 3Results posted
• A Study of Adalimumab in Japanese Subjects With Rheumatoid ArthritisCompletedNCT00870467Phase 3Results posted
• Living Well With Rheumatoid ArthritisCompletedNCT00869349Not applicableResults posted
• Study Comparing The Effect On Disease Activity When Reducing Or Discontinuing Etanercept In Subjects With RACompletedNCT00858780Phase 4Results posted
• A Study Comparing 2 Doses Of CP-690,550 Vs. Placebo For The Treatment Of Rheumatoid Arthritis In Patients On Other Background Arthritis MedicationsCompletedNCT00856544Phase 3Results posted
• Prospective Multicenter Post Approval Study of the LPS-Flex Mobile Bearing KneeCompletedNCT00854295Not applicableResults posted
• A Phase 3 Study Comparing 2 Doses Of CP-690,550 And The Active Comparator, Humira (Adalimumab) Vs. Placebo For Treatment Of Rheumatoid ArthritisCompletedNCT00853385Phase 3Results posted
• Open-Label Study Comparing Etanercept to Conventional Disease Modifying Antirheumatic Drug (DMARD) TherapyCompletedNCT00848354Phase 4Results posted
• A Study to Assess the Effect of Tocilizumab on Signs and Symptoms in Patients With Rheumatoid ArthritisCompletedNCT00848120Phase 3Results posted
• Study of LX3305 and Methotrexate in Subjects With Stable Rheumatoid ArthritisCompletedNCT00847886Phase 1Results posted
• A 2-Year Phase 3 Study Of CP-690,550 In Patients With Active Rheumatoid Arthritis On Background MethotrexateCompletedNCT00847613Phase 3Results posted
• A Study of Combination Treatment With MabThera (Rituximab) and RoActemra (Tocilizumab) Versus RoActemra in Patients With Rheumatoid Arthritis With an Incomplete Response to MethotrexateTerminatedNCT00845832Phase 2Results posted
• Cardiovascular Risk Markers in Patients With Rheumatoid Arthritis: Effect of Rituximab TherapyCompletedNCT00844714Not applicableResults posted
• Follow-up of Rheumatoid Arthritis (RA) Moderate to Low Disease Activity StudyCompletedNCT00843778Phase 3Results posted
• Phase I Study Of The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Multiple Intravenously Administered Doses Of PF-04236921 In Patients With Rheumatoid ArthritisCompletedNCT00838565Phase 1Results posted
• An Open Label Extension Study in Participants With Rheumatoid ArthritisCompletedNCT00837811Phase 2Results posted
• Anti-TNF Agents for the Treatment of Rheumatoid ArthritisCompletedNCT00837434Phase 4Results posted
• A Phase 3 Study Comparing 2 Doses of CP-690,550 vs. Placebo for Treatment of Rheumatoid ArthritisCompletedNCT00814307Phase 3Results posted
• A Study of Tocilizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Current Non-Biologic DMARDsCompletedNCT00810277Phase 3Results posted
• A Study of Tocilizumab and Methotrexate Treatment Strategies (Adding Tocilizumab to Methotrexate Versus Switching to Tocilizumab) in Patients With Active Rheumatoid Arthritis With Inadequate Response to Prior Methotrexate TreatmentCompletedNCT00810199Phase 3Results posted
• Efficacy of AIN457 in Adults (18-65 Years) With Psoriatic ArthritisCompletedNCT00809614Phase 2Results posted
• A Pilot Study of the Feasibility of Discontinuation of Adalimumab in Stable Rheumatoid Arthritis Patients in Clinical RemissionCompletedNCT00808509Phase 4Results posted
• A Study to Evaluate Ocrelizumab in Combination With Methotrexate Compared With Infliximab Plus Methotrexate in Patients With Active Rheumatoid Arthritis Currently Responding Inadequately to Etanercept or AdalimumabTerminatedNCT00808210Phase 2Results posted
• A Study To Evaluate The Effects Of Celecoxib (Celebrex®) Or Naproxen On Blood Pressure In Pediatric SubjectsCompletedNCT00807846Phase 4Results posted
• Open-Label, Multicenter Extension Study for Patients Completing Treatment Phase of a Rigel-Sponsored R935788 StudiesTerminatedNCT00805467Phase 2Results posted
• Switching Anti-TNF-Alpha Agents in Rheumatoid Arthritis (RA)TerminatedNCT00796705Phase 4Results posted
• Drug Outcome Survey for Biological Treatments in Rheumatoid Arthritis: an Observational Study (Dose)CompletedNCT00794118Results posted
• Current Adoption of Composite Indices in Evaluating Rheumatoid Arthritis Patients: An Observational StudyCompletedNCT00793403Results posted
• Efficacy Confirmation Trial of CDP870 as add-on Medication to Methotrexate (MTX) in Japanese Rheumatoid Arthritis (RA)CompletedNCT00791999Phase 2/3Results posted
• Efficacy Confirmation Trial of CDP870 Without Coadministration of Methotrexate (MTX) in Japanese Rheumatoid Arthritis (RA)CompletedNCT00791921Phase 3Results posted
• Single Dose PG102 in Patients With Active Psoriatic ArthritisTerminatedNCT00787137Phase 1Results posted
• A Study for Patients With Active Rheumatoid Arthritis Despite Ongoing Methotrexate TherapyCompletedNCT00785928Phase 2Results posted
• A Study to Compare the Frequency of Constipation Symptoms With Tapentadol Immediate Release (IR) Treatment Versus Oxycodone IR Treatment in Patients With End-stage Joint DiseaseCompletedNCT00784277Phase 3Results posted
• Active Juvenile Idiopathic Arthritis (JIA) Compassionate UseCompletedNCT00775437Phase 3Results posted
• A Study of Tocilizumab in Combination With DMARD Therapy in Patients With Active Rheumatoid Arthritis.CompletedNCT00773461Phase 3Results posted
• Study to Evaluate the Safety, PK, PD and Efficacy of AMG 827 in Adults With Rheumatoid ArthritisCompletedNCT00771030Phase 1/2Results posted
• Evaluation of EULAR-RAID Score in Rheumatoid Arthritis PatientsCompletedNCT00768053Phase 4Results posted
• A Rheumatoid Arthritis Study to Assess Early Response to Abatacept+MTX as Defined by Improvement of Synovitis Measures by Power Doppler UltrasonographyCompletedNCT00767325Phase 3Results posted
• Mobile - Bearing Knee StudyCompletedNCT00765362Phase 3Results posted
• Retrospective Encore Reverse Shoulder Prosthesis StudyCompletedNCT00765037Results posted
• The 3DKnee™ System: A Post-Market StudyCompletedNCT00764673Phase 4Results posted
• Inflammation and Insulin Resistance in Rheumatoid ArthritisCompletedNCT00763139Not applicableResults posted
• Evaluation of Quality of Life Changes in Puerto Rican Subjects With Active Rheumatoid Arthritis Treated With HumiraTerminatedNCT00761514Phase 4Results posted
• An Observational Study of Infliximab Injection in Ankylosing Spondylitis, Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis ParticipantsCompletedNCT00760669Results posted
• A Study to Assess the Effect of Tocilizumab Plus Methotrexate on Safety and Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid ArthritisCompletedNCT00754572Phase 3Results posted
• A Study to Assess Efficacy With Respect to Clinical Improvement in Disease Activity and Safety of Tocilizumab in Patients Wtih Active Rheumatoid Arthritis.CompletedNCT00754559Phase 3Results posted
• Open Label Extension for Patients Coming From the Dosing Flexibility Study in Patients With Rheumatoid Arthritis (RA)CompletedNCT00753454Phase 3Results posted
• An Exploratory Study of Tocilizumab in Patients With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Current Non-Biologic DMARDs and/or Anti-TNF Therapy.CompletedNCT00750880Phase 3Results posted
• A Study Comparing CRx-102 Plus Disease-modifying Anti-rheumatic Drug (DMARD) Therapy to Placebo Plus DMARD Therapy in RACompletedNCT00747214Phase 2Results posted
• A Study of the Effects of Oral Prednisone in Patients With Rheumatoid Arthritis (MK0000-088)CompletedNCT00746512Phase 1Results posted
• A Feasibility Study Exploring the Effect of Remicade on the Disease Activity in RA Patients (Study P05417)CompletedNCT00741104Results posted
• Post Marketing Surveillance Study of Remicade in Patients With Chronic Inflammatory Diseases (P04840)CompletedNCT00727298Results posted
• Real Life Dosing of Remicade for Rheumatoid Arthritis in Austria Monitored Over 9 Infusions (Study P03756)(COMPLETED)CompletedNCT00725621Results posted
• Investigation of 9 Consecutive Infusions of Remicade for Psoriatic Arthritis in Austria (Study P04264)CompletedNCT00725296Results posted
• Safety and Effectiveness of Infliximab in Slovakia When Used for Rheumatoid Arthritis (Study P04741)(COMPLETED)CompletedNCT00724243Results posted
• Cormet Post-PMA Study: New EnrollmentCompletedNCT00722007Not applicableResults posted
• A Long-term Extension Study of Tocilizumab (Myeloma Receptor Antibody [MRA]) in Patients With Rheumatoid ArthritisCompletedNCT00721123Phase 3Results posted
• An Extension Study of Tocilizumab (Myeloma Receptor Antibody [MRA]) in Patients Completing Treatment in Tocilizumab Core StudiesCompletedNCT00720798Phase 3Results posted
• A Study of Effectiveness and Safety of CNTO 136 in Patients With Active Rheumatoid Arthritis Despite Methotrexate TherapyCompletedNCT00718718Phase 2Results posted
• Certolizumab Pegol for the Treatment of Patients With Active Rheumatoid ArthritisCompletedNCT00717236Phase 3Results posted
• Trilogy AB Acetabular Hip System Post Approval StudyTerminatedNCT00715026Phase 4Results posted
• RESTART C0168Z05 Rheumatoid Arthritis StudyCompletedNCT00714493Phase 4Results posted
• A Proof of Concept and Dose Ranging Study in Patients With Rheumatoid ArthritisCompletedNCT00713544Phase 2Results posted
• Study Evaluating Efficacy / Safety of Etanercept + Methotrexate Compared to Usual Treatment in Moderate RA SubjectsTerminatedNCT00706797Phase 4Results posted
• A Study to Observe Characteristics of Rheumatoid Arthritis in Patients Using Infliximab (Study P04250)CompletedNCT00705289Results posted
• A Clinical Investigation of the Discovery™ Elbow SystemCompletedNCT00698867Results posted
• Methotrexate Polyglutamate Levels as a Marker for the Clinical Outcome in the Treatment of Rheumatoid ArthritisCompletedNCT00695188Phase 4Results posted
• Safety, Efficacy, and Pharmacokinetics of Adalimumab in Japanese Children With Juvenile Rheumatoid ArthritisCompletedNCT00690573Phase 3Results posted
• A Study for Patients With Rheumatoid Arthritis on Methotrexate (MTX) With an Inadequate Response to TNFα Inhibitor TherapyCompletedNCT00689728Phase 2Results posted
• Naturalistic Safety Registry Of Celecoxib (CELEBREX(R)) And NSAIDs In Juvenile Idiopathic ArthritisTerminatedNCT00688545Results posted

← Arthritis overview